How has been the historical performance of Rossari Biotech?

Answer:The historical performance of Rossari Biotech shows a consistent growth trend in net sales and profitability over the years.

Breakdown:
Rossari Biotech's net sales have increased significantly from INR 600.09 crore in March 2020 to INR 2,080.29 crore in March 2025. This growth is reflected in the total operating income, which rose from INR 600.09 crore in March 2020 to INR 2,080.29 crore in March 2025. The company's operating profit (PBDIT) also demonstrated a positive trend, climbing from INR 108.46 crore in March 2020 to INR 269.08 crore in March 2025. Profit before tax increased from INR 88.06 crore in March 2020 to INR 184.21 crore in March 2025, while profit after tax rose from INR 65.47 crore to INR 135.40 crore during the same period. The earnings per share (EPS) improved from INR 12.86 in March 2020 to INR 24.64 in March 2025, indicating enhanced shareholder value. On the balance sheet, total assets grew from INR 471.46 crore in March 2020 to INR 1,885.67 crore in March 2025, with total liabilities also increasing from INR 471.46 crore to INR 1,885.67 crore. The cash flow from operating activities showed a marked improvement, rising from INR 56 crore in March 2020 to INR 137 crore in March 2025, while the net cash inflow turned positive at INR 19 crore in March 2025, compared to a net outflow of INR 44 crore in March 2024. Overall, Rossari Biotech has demonstrated robust growth in sales, profitability, and cash flow over the years.